Glenmark’s licensing deal with Novartis to distribute three respiratory drugs in Brazil
Glenmark Farmacêutica, has entered into an exclusive partnership agreement with Novartis to distribute latter’s three respiratory products in Brazil. Under the terms... Read More
A triple-combination therapy for COPD – Breztri Aerosphere’s of AstraZeneca received approval in Japan
Posted on21 Jun 2019
Comments0
AstraZeneca announced that Breztri Aerosphere (budesonide/ glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve... Read More
Pharma Case Study : Vertical Integration – Relevium’s acquisition of Lifeline Pharma SAS
Posted on14 Jun 2019
Comments0
Relevium Technologies Inc., is pleased to announce that Biocannabix Health Corporation, a wholly-owned subsidiary of Relevium has executed on June 12, 2019... Read More
Case Study: USFDA approval of Exeltis’s Slynd, an oral contraceptive tablet
Exeltis USA, Inc. a division of the global pharmaceutical group Insud Pharma, announced that the US Food and Drug Administration (FDA) has... Read More
Case analysis: Can marketing authorization can be revoked?
Yes. Marketing authorization can be revoked and it generally carried out, in case of safety issued observed with the molecule. Here is... Read More
Luye Pharma’s Rykindo NDA Filing Accepted by the US FDA
Rykindo, Luye Pharma’s innovative, independently developed Extended-Release Microspheres formulation for injection, is one step closer to going on the U.S. market. The... Read More
Top 10 Generic Company Globally in 2018 (by revenue)
Here you can preview top 10 global generic companies by revenue. Data is presented in USD million. Click here to view the... Read More
Top 10 Global Pharmaceutical Company in 2018
Posted on26 May 2019
Comments0
Sanofi’s Praluent got much needed boost with USFDA new indication approval
The Food and Drug Administration (FDA) has approved Praluent (alirocumab; Sanofi and Regeneron), a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor,... Read More
Calixar licensing agreement with Regeneron
Calixar SAS, a biotechnology company specialized in native membrane protein stabilization, has entered into an exclusive licensing agreement with Regeneron Pharmaceuticals, Inc.... Read More